Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2018, Article ID 1739615, 10 pages
https://doi.org/10.1155/2018/1739615
Research Article

Predictive Value of Combined LIPS and ANG-2 Level in Critically Ill Patients with ARDS Risk Factors

1Institute of Respiratory Disease, Department of Respiratory, Respiratory Intensive Care Unit, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
2Emergency Department, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
3Gastroenterology Department, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
4Department of Neurosurgery, Neurosurgical Intensive Care Unit, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
5Intensive Care Unit, Daping Hospital, Third Military Medical University, Chongqing 400042, China
6Department of Respiratory, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
7Department of Respiratory, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400011, China

Correspondence should be addressed to Chun-Xia Mei; moc.361@xcm1111 and Guan-Song Wang; moc.361@3002sggnaw

Received 29 November 2017; Revised 12 April 2018; Accepted 16 April 2018; Published 12 June 2018

Academic Editor: Giuseppe Valacchi

Copyright © 2018 Zhi Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ARDS Definition Task Force, V. M. Ranieri, G. D. Rubenfeld et al., “Acute respiratory distress syndrome: the Berlin definition,” JAMA, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. B. P. Amato, C. S. V. Barbas, D. M. Medeiros et al., “Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome,” New England Journal of Medicine, vol. 338, no. 6, pp. 347–354, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. Acute Respiratory Distress Syndrome Network, R. G. Brower, M. A. Matthay et al., “Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome,” New England Journal of Medicine, vol. 342, no. 18, pp. 1301–1308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. O. Meade, D. J. Cook, G. H. Guyatt et al., “Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial,” JAMA, vol. 299, no. 6, pp. 637–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. V. Murphy, G. E. Schramm, J. A. Doherty et al., “The importance of fluid management in acute lung injury secondary to septic shock,” Chest, vol. 136, no. 1, pp. 102–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. G. Spragg, G. R. Bernard, W. Checkley et al., “Beyond mortality: future clinical research in acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 10, pp. 1121–1127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Trillo-Alvarez, R. Cartin-Ceba, D. J. Kor et al., “Acute lung injury prediction score: derivation and validation in a population based sample,” European Respiratory Journal, vol. 37, no. 3, pp. 604–609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Gajic, O. Dabbagh, P. K. Park et al., “Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 4, pp. 462–470, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Kor, D. O. Warner, A. Alsara et al., “Derivation and diagnostic accuracy of the surgical lung injury prediction model,” Anesthesiology, vol. 115, no. 1, pp. 117–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Levitt, H. Bedi, C. S. Calfee, M. K. Gould, and M. A. Matthay, “Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure,” Chest, vol. 135, no. 4, pp. 936–943, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Matthay and R. L. Zemans, “The acute respiratory distress syndrome: pathogenesis and treatment,” Annual Review of Pathology: Mechanisms of Disease, vol. 6, no. 1, pp. 147–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Pierrakos, M. Karanikolas, S. Scolletta, V. Karamouzos, and D. Velissaris, “Acute respiratory distress syndrome: pathophysiology and therapeutic options,” Journal of Clinical Medicine Research, vol. 4, no. 1, pp. 7–16, 2012. View at Publisher · View at Google Scholar
  14. A. Takala, I. Jousela, O. Takkunen et al., “A prospective study of inflammation markers in patients at risk of indirect acute lung injury,” Shock, vol. 17, no. 4, pp. 252–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Bouros, M. G. Alexandrakis, K. M. Antoniou et al., “The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for acute respiratory distress syndrome,” BMC Pulmonary Medicine, vol. 4, no. 1, p. 6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Donnelly, C. Haslett, R. M. Strieter et al., “Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups,” The Lancet, vol. 341, no. 8846, pp. 643–647, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Sporek, P. Dumnicka, A. Gala-Bladzinska et al., “Angiopoietin-2 is an early indicator of acute pancreatic-renal syndrome in patients with acute pancreatitis,” Mediators of Inflammation, vol. 2016, Article ID 5780903, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Gallagher, S. M. Parikh, K. Balonov et al., “Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome,” Shock, vol. 29, no. 6, pp. 656–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. van der Heijden, G. P. van Nieuw Amerongen, P. Koolwijk, V. W. M. van Hinsbergh, and A. B. J. Groeneveld, “Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients,” Thorax, vol. 63, no. 10, pp. 903–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Wada, S. Jesmin, S. Gando et al., “The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness,” Journal of Inflammation, vol. 10, no. 1, p. 6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II-a severity of disease classification system: reply,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Chest, vol. 101, no. 6, pp. 1644–1655, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. d. S. Cardoso and P. A. Chiavone, “The APACHE II measured on patients’ discharge from the intensive care unit in the prediction of mortality,” Revista Latino-Americana de Enfermagem, vol. 21, no. 3, pp. 811–819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. I. B. Lobov, P. C. Brooks, and R. A. Lang, “Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo,” Proceedings of the National Academy of Sciences, vol. 99, no. 17, pp. 11205–11210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. R. Ricciuto, C. C. d. Santos, M. Hawkes et al., “Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis,” Critical Care Medicine, vol. 39, no. 4, pp. 702–710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Chung, Y. Wu, Q. Okobi et al., “Proinflammatory cytokines IL-6 and TNF-α increased telomerase activity through NF-κB/STAT1/STAT3 activation, and withaferin A inhibited the sin colorectal cancer cells,” Mediators of Inflammation, vol. 2017, Article ID 5958429, 11 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Nishida, M. Aino, S. I. Kobayashi et al., “Serum amyloid A promotes E-selectin expression via toll-like receptor 2 in human aortic endothelial cells,” Mediators of Inflammation, vol. 2016, Article ID 7150509, 8 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Okajima, N. Harada, G. Sakurai et al., “Rapid assay for plasma soluble E-selectin predicts the development of acute respiratory distress syndrome in patients with systemic inflammatory response syndrome,” Translational Research, vol. 148, no. 6, pp. 295–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Agrawal, M. A. Matthay, K. N. Kangelaris et al., “Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 7, pp. 736–742, 2013. View at Publisher · View at Google Scholar · View at Scopus